Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae

Journal of Clinical Laboratory Analysis

Volumn 11, Issue 3, 1997, Pages 175-178

  Harima, Helena A ^a,c   Mendes, Nelson F ^a   Mamizuka, Elsa M ^b   Mariano, Mario ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Edif de Cie Biomed ^*  (Brazil)

Author keywords

glucan; immunomodulation; Klebsiella; lupus; resistance

Indexed keywords

GLUCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION RESISTANCE; KLEBSIELLA PNEUMONIAE; LUPUS ERYTHEMATOSUS; MACROPHAGE; MORTALITY; MOUSE; NONHUMAN; SEPTIC SHOCK;

ANIMALS; FEMALE; GLUCANS; IMMUNITY, ACTIVE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED NZB; PERITONITIS; SURVIVAL RATE;

EID: 0030955098     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1997)11:3<175::AID-JCLA10>3.0.CO;2-T     Document Type: Article

References (26)

1. Theofilopoulos AN, Dixon FJ: Murine models of systemic lupus erythematosus. Adv Immunol 37:269-390, 1985.
2. Steinberg AD, Klinman DM, Kaster DL, Seldin MF, Gause WC, Scribner CL, Britten JL, Siegel JN, Mountz JD: Genetic and molecular genetic studies of murine and human lupus. J Rheumatol 14(suppl. 13): 166-176, 1987.
3. Russel PJ, Steinberg AD: Studies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin Immunol Immunopathol 27:387-402, 1983.
4. Jacob CO, McDevitt HO: Tumor necrosis factor-α in murine autoimmune lupus nephritis. Nature 331:356-358, 1988.
5. Dore-Duffy P, Guha A, Rothman BL, Zurier RB: Synthesis of prostaglandin E by peritoneal macrophages from NZB/W mice. Life Sci 42:2669-2676, 1988.
6. Hassid WZ, Hoslyn MA, McCready RM: The molecular constitution of an insoluble polysaccharide from yeast Saccharomyces cerevisiae. J Am Chem Soc, 63:295-298, 1941.
7. Wooles WR, Di Luzio NR: Reticuloendothelial function and immune response. Science 142:1078-1080, 1963.
8. Di Luzio NR: Update on the immunomodulating activities of glucans. Springer Semin Immunopathol 8:387-400, 1985.
9. Franék, Malina J, Krátká H: Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms. Folia Microbiol (Praha) 37:146-152, 1992.
10. Wooles WR, Di Luzio NR: The phagocytic and proliferative response of the reticuloendothelial system following glucan administration. J Reticuloendothel Soc 1:160-169, 1964.
11. Di Luzio NR, Morrow HS III: Comparative behavior of soluble and particulate antigens and inert colloids in reticuloendothelial-stimulated or depressed mice. J Reticuloendothel Soc 9:273-287, 1971.
12. Sherwood ER, Williams DL, McNamee RB, Jones EL, Browder IM, Di Luzio NR: Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. Int J Immunopharmacol 9:261-267, 1987.
13. 2 production but not antigen-presenting function. J Leukoc Biol 49:342-351, 1991.
14. Reynolds JA, Kastello MD, Harrington DG, Crabbs CL, Petters CJ, Jemski JV, Scott GH, Di Luzio NR: Glucan-induced enhancement of host resistance to selected infectious diseases. Infect Immun 30:51-57, 1980.
15. Di Luzio NR, Williams DL, Sherwood ER, Browder IW: Modification of diverse experimental immunosuppressive states by glucan. Surv Immunol Res 4:160-167, 1985.
16. Holbrook TW, Cook JA: Immunization of mice against Leishmania donovani by subcutaneous injections of dead promastigotes. Am J Trop Med Hyg 32:51-53, 1983.
17. Snyder AR, Levine S: Modulation of experimental allergic encephalomyelitis with yeast glucan and methyl palmitate to alter the activity of the reticuloendothelial system. J Reticuloendothel Soc 28:49-54, 1980.
18. Pérez HA, Bolivar J, San Blas G: The immunomodulatory effect of yeast glucan on delayed hypersensitivity. J Immunopharmacol 6:305-321, 1984.
19. Pospísil M, Tkadlecek L, Netíková J, Pipalová I, Viklická S, Kozubik A, Vácha J, Jarý J; Interstrain differences in the responsiveness of mice to glucan with respect to hematological effects and manifestations of late damage. Exp Pathol 33:27-33, 1988.
20. Staples PJ, Talal N: Relative inability to induce tolerance in adult NZB and NZB/NZW F1 mice. J Exp Med 129:123-139, 1969.
21. Norins LC, Holmes MC: Antinuclear factor in mice. J Immunol 93:148-154, 1964.
22. de Felipe Júnior J. da Rocha a Silva Junior M, Maciel FMB, Soares AM, Mendes NF: Infection prevention in patients with severe multiple trauma with the immunomodulator β 1-3polyglucose (glucan). Surg Gynecol Obstet 177:383-388, 1993.
23. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA: Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 220:601-609, 1994.
24. Dubois EL, Horowitz RE, Demopoulos HB.Teplitz R: NZB/NZW mice as a model of systemic lupus erythematosus. JAMA 195:285-289, 1966
25. Steinberg AD, Baron S, Talal N: The pathogenesis of autoimmunity in New Zealand mice. I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci USA 63:1102-1107, 1969.
26. Theofilopoulos AN, Shawler DL, Eisenberg RA, Dixon FJ: Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med 151:446-466, 1980.